Medical Health & Life Science Research News

Learn details of Latin America's cancer monoclonal antibodies market

Learn details of Latin America's cancer monoclonal antibodies market

Latin America Cancer Monoclonal Antibodies Market by application (Liver, Breast, Blood, Brain, Hodgkin’s and Non-Hodgkin’s lymphoma, Colorectal, leukaemia and others) by type (murine antibodies, chimeric and humanised antibodies and fully humanized antibodies)

- Advertising -

According to the report Latin America Cancer Monoclonal Antibodies Market, published by Market Data Forecast, The Global market has been estimated at USD 3.24 billion in 2015 and is projected to reach USD 5.1 billion by the end of 2020, at a CAGR of 9.5% during the forecast period from 2015 to 2020

Browse market data tables and in-depth TOC of the Latin America Cancer Monoclonal Antibodies Market to 2020 at www.marketdataforecast.com/market-…odies-market-189/

Cancer is a severe diseases causing millions of death worldwide every year. Cancer starts from a single cell and genetically transforms a normal cell in to tumour cell and is gradually spread to other cells.

With the dramatic increase in the number of people affected by cancer, many pharmaceutical players started to invest on monoclonal antibodies. While the drugs are used for the treatment of cancer, drugs like chemotherapy agents have adverse side effects as they affect the normal cells as well along with cancerous cells.

- Advertising -

This prompted the increased usage of Monoclonal Antibodies for the treatment of cancer.

Report: www.marketdataforecast.com/cart/la…bodies-market-189

Report: www.marketdataforecast.com/market-…89/request-sample

Recent years have seen the emergence of monoclonal antibodies market, offering less toxic and highly efficient therapeutics alternatives. The antibody agents are used to cure a wide array of diseases, especially cancer, autoimmune and inflammatory diseases.

They are mono-specific antibodies having identical immune cells that are clone to the single parent cells and are directed to a specific target cell. This customizable feature of the antibodies due to its specific nature can play a critical role in eliminating the cancer cell while sparing the healthy cells.

Monoclonal antibodies are more effective in treating cancer than their counter parts like drugs or chemotherapy owing to their adverse side effects.

Latin America Cancer Monoclonal Antibodies Market : Segmentation

 

  • By Application                                                                           

 

  • By Type                                                                        
  • Conjugate Cancer Therapies                                                                               
  • Geographical Analysis    

                                                                                   

  • Brazil                                                                                            
  • Mexico                                                                                         
  • Rest of Latin America 

The major players in the Cancer Monoclonal Antibodies Market

 

  • Amgen
  • Genmab
  • Glaxosmithkline
  • Bristol Myers Squibb
  • Roche
  • Eli Lilly
  • Immunogen
  • Novartis
  • Seattle Genetics
  • Spectrum Pharmaceuticals.

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...